Four Keys to a Smoother Clinical Development Journey
Whitepaper recently published in Fierce Biotech providing perspectives on how the right partner can help bring all the disciplines together for a successful development program.
Drug development requires the efforts of a broad set of disciplines as well as nonclinical, clinical, regulatory and commercial experts. An integrated strategy that considers innovative trial designs and patient centricity can improve efficiency, reduce costs, and shorten development timelines.
This white paper discusses:
- The importance of integrating clinical and regulatory strategies
- Approaches to new clinical trial designs and technologies
- Patient centricity inclusion throughout the development process
- Traits to look for in CRO partners